Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hot spot-based design of small-molecule inhibitors for protein–protein interactions
Wenxing Guo, John A. Wisniewski, Haitao Ji
Bioorganic & Medicinal Chemistry Letters (2014) Vol. 24, Iss. 11, pp. 2546-2554
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Michelle R. Arkin, Yinyan Tang, James A. Wells
Chemistry & Biology (2014) Vol. 21, Iss. 9, pp. 1102-1114
Open Access | Times Cited: 955
Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
Krzysztof M. Zak, Radosław Kitel, Sara Przetocka, et al.
Structure (2015) Vol. 23, Iss. 12, pp. 2341-2348
Open Access | Times Cited: 470
SKEMPI 2.0: an updated benchmark of changes in protein–protein binding energy, kinetics and thermodynamics upon mutation
Justina Jankauskaitė, Brian Jiménez‐García, Justas Dapkūnas, et al.
Bioinformatics (2018) Vol. 35, Iss. 3, pp. 462-469
Open Access | Times Cited: 270
Modulation of Protein–Protein Interactions for the Development of Novel Therapeutics
Ιωάννα Πέττα, Sam Lievens, Claude Libert, et al.
Molecular Therapy (2015) Vol. 24, Iss. 4, pp. 707-718
Open Access | Times Cited: 200
Supramolecular Chemistry Targeting Proteins
Sam van Dun, Christian Ottmann, L.‐G. Milroy, et al.
Journal of the American Chemical Society (2017) Vol. 139, Iss. 40, pp. 13960-13968
Open Access | Times Cited: 188
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Haohao Zhu, Hui Gao, Yingying Ji, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Targeting Class I Histone Deacetylases in a “Complex” Environment
Christopher J. Millard, Peter J. Watson, Louise Fairall, et al.
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 4, pp. 363-377
Closed Access | Times Cited: 159
State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
Chunquan Sheng, Guoqiang Dong, Zhenyuan Miao, et al.
Chemical Society Reviews (2015) Vol. 44, Iss. 22, pp. 8238-8259
Closed Access | Times Cited: 148
Flexibility and small pockets at protein–protein interfaces: New insights into druggability
Harry Jubb, Tom L. Blundell, David B. Ascher
Progress in Biophysics and Molecular Biology (2015) Vol. 119, Iss. 1, pp. 2-9
Open Access | Times Cited: 144
Peptide Backbone Composition and Protease Susceptibility: Impact of Modification Type, Position, and Tandem Substitution
Halina M. Werner, Chino C. Cabalteja, W. Seth Horne
ChemBioChem (2015) Vol. 17, Iss. 8, pp. 712-718
Open Access | Times Cited: 135
Current NMR Techniques for Structure-Based Drug Discovery
Toshihiko Sugiki, Kyoko Furuita, Toshimichi Fujiwara, et al.
Molecules (2018) Vol. 23, Iss. 1, pp. 148-148
Open Access | Times Cited: 109
Direct targeting of β‐catenin in the Wnt signaling pathway: Current progress and perspectives
Zhen Wang, Zilu Li, Haitao Ji
Medicinal Research Reviews (2021) Vol. 41, Iss. 4, pp. 2109-2129
Open Access | Times Cited: 98
Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective
Maria Maddalena Cavalluzzi, Giuseppe Felice Mangiatordi, Orazio Nicolotti, et al.
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 11, pp. 1087-1104
Open Access | Times Cited: 96
Thioredoxin reductase inhibitors: a patent review
Baoxin Zhang, Junmin Zhang, Shoujiao Peng, et al.
Expert Opinion on Therapeutic Patents (2016) Vol. 27, Iss. 5, pp. 547-556
Closed Access | Times Cited: 92
Hot-spot analysis for drug discovery targeting protein-protein interactions
Mireia Rosell, Juan Fernández‐Recio
Expert Opinion on Drug Discovery (2018) Vol. 13, Iss. 4, pp. 327-338
Closed Access | Times Cited: 86
Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
Mohammad Hassan Baig, Khurshid Ahmad, Jun Sung Moon, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 60
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
Lin Wang, Yan Wu, Sheng Yao, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 4, pp. 788-796
Open Access | Times Cited: 59
Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy: Mechanisms of Action and Other Considerations for Their Advanced Development
Pottayil G. Sasikumar, Murali Ramachandra
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
β-catenin inhibitors in cancer therapeutics: intricacies and way forward
Arundhathi Dev, Meenakshi Vachher, Chandra Prakash Prasad
Bioengineered (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Privileged scaffolds in lead generation
Hongyu Zhao, Justin Dietrich
Expert Opinion on Drug Discovery (2015) Vol. 10, Iss. 7, pp. 781-790
Closed Access | Times Cited: 83
Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs – An Ab Initio Fragment Molecular Orbital Study
Sundaram Arulmozhiraja, Naoya Matsuo, Erika Ishitsubo, et al.
PLoS ONE (2016) Vol. 11, Iss. 11, pp. e0166275-e0166275
Open Access | Times Cited: 81
Protein Activity Regulation: Inhibition by Closed-Loop Aptamer-Based Structures and Restoration by Near-IR Stimulation
Jie Wang, Yurong Wei, Xiaoxia Hu, et al.
Journal of the American Chemical Society (2015) Vol. 137, Iss. 33, pp. 10576-10584
Closed Access | Times Cited: 73
Deciphering the Lexicon of Protein Targets: A Review on Multifaceted Drug Discovery in the Era of Artificial Intelligence
Suvendu Nandi, Soumyadeep Bhaduri, Debraj Das, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1563-1590
Closed Access | Times Cited: 7
14‐3‐3 Protein‐Protein Interactions: From Mechanistic Understanding to Their Small‐Molecule Stabilization
B. Somsen, Peter J. Cossar, Michelle R. Arkin, et al.
ChemBioChem (2024) Vol. 25, Iss. 14
Open Access | Times Cited: 6
Rational Design of Selective Small-Molecule Inhibitors for β-Catenin/B-Cell Lymphoma 9 Protein–Protein Interactions
Logan R. Hoggard, Yongqiang Zhang, Min Zhang, et al.
Journal of the American Chemical Society (2015) Vol. 137, Iss. 38, pp. 12249-12260
Closed Access | Times Cited: 63
Page 1 - Next Page

Scroll to top